Pcn43 - A Targeted Review of Nice Single Technology Appraisals (Stas) in Urothelial Cancer Since the Introduction of the New Cancer Drugs Fund (Cdf)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.125
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV